Evolution of the Average Target: Amarin Corporation plc

Evolution of the Target Price: Amarin Corporation plc

Changes in Analyst Recommendations: Amarin Corporation plc

c8fb58f9c8aaf1a.bkaMmibEQ1EPAHm0s3pWkMGJ_BVytwG2bio6RMJ3iVc.KCjZ-X_yFAJ-YkHx_k1gpaPqxWQ1hkTwHmB_c6AQ-jVeCe-rc5ccAkFpDg~8c0357c2f7b7791dcc6790e483a09640
27/25/27 Amarin issues statement supporting FDA's action to revise labeling for fenofibrate drugs reinforcing a lack of cardiovascular benefit RE
25/25/25 RBC Ups Recordati's Price Target on Cardiovascular Drug European Licensing Deal MT
25/23/25 Jefferies Downgrades Amarin to Hold From Buy, Cuts Price Target to $1 From $3 MT
19/23/19 Northland Adjusts Price Target on Amarin to $1.25 From $2, Maintains Market Perform Rating MT
06/23/06 Jefferies Upgrades Amarin to Buy From Hold, Adjusts Price Target to $3 From $1.30 MT
19/22/19 SVB Securities Adjusts Amarin's Price Target to $2 From $3, Maintains Market Perform Rating MT
06/22/06 JPMorgan Downgrades Amarin to Underweight From Neutral MT
05/22/05 HC Wainwright Lowers Amarin to Neutral From Buy, Price Target to $3 From $10 MT
05/22/05 SVB Leerink Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $3 From $10 MT
05/22/05 Northland Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $2 From $9 MT
16/22/16 SVB Leerink Adjusts Amarin's Price Target to $10 from $11, Maintains Outperform Rating MT
31/22/31 SVB Leerink Adjusts Amarin's Price Target to $11 from $12, Keeps Outperform Rating MT
12/21/12 AMARIN : Goldman Sachs Downgrades Amarin to Sell From Neutral, Adjusts Price Target to $5 From $6 MT
01/21/01 AMARIN : SVB Leerink Adjusts Price Target on Amarin to $16 From $12, Maintains Outperform Rating MT
23/20/23 AMARIN : Goldman Sachs Adjusts Amarin's Price Target to $6 From $8, Maintains Neutral Rating MT
07/20/07 AMARIN : Citigroup Adjusts Amarin's Price Target to $7 from $12, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - -15.25%
+16.94%
+18.95%
+31.23%
+90.25%
+19.59%
+28.12%
+13.97%
-5.9%
-0.62%
Average +19.73%
Weighted average by Cap. +24.18%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
14.16USD
Average target price
12.00USD
Spread / Average Target
-15.25%
High Price Target
12.00USD
Spread / Highest target
-15.25%
Low Price Target
12.00USD
Spread / Lowest Target
-15.25%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Jefferies & Co.
Northland Securities
SVB Securities LLC
JPMorgan Chase
SVB Leerink
HC Wainwright
Goldman Sachs
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
14.16USD
Average target price
12.00USD
Spread / Average Target
-15.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock
  4. Consensus Amarin Corporation plc